214 related articles for article (PubMed ID: 11920204)
1. Is there a limit to the normality of blood products?
Degos L
Hematol J; 2000; 1(5):291. PubMed ID: 11920204
[No Abstract] [Full Text] [Related]
2. Transfusion associated infections: a threat to life.
Malla N; Ratho RK; Mishra B; Grover R; Mahajan RC
J Indian Med Assoc; 2003 Jan; 101(1):18, 20-3. PubMed ID: 12841502
[TBL] [Abstract][Full Text] [Related]
3. Safety of the blood supply.
Sloand EM; Pitt E; Klein HG
JAMA; 1995 Nov; 274(17):1368-73. PubMed ID: 7563562
[No Abstract] [Full Text] [Related]
4. The role of leukodepletion in the control of transfusion-transmitted disease.
Goldman M; Delage G
Transfus Med Rev; 1995 Jan; 9(1):9-19. PubMed ID: 7719040
[No Abstract] [Full Text] [Related]
5. Autotransfusion in vascular surgery: an overview.
Tawes RL
Semin Vasc Surg; 1994 Jun; 7(2):67-71. PubMed ID: 8087282
[No Abstract] [Full Text] [Related]
6. Current issues in transfusion therapy. 1. Risks of infection.
Coffin CM
Postgrad Med; 1986 Dec; 80(8):219-24. PubMed ID: 3786281
[TBL] [Abstract][Full Text] [Related]
7. Parasitic infection from blood transfusions.
Shulman IA
MLO Med Lab Obs; 1992 Sep; 24(9):55-6, 58, 60. PubMed ID: 10121593
[No Abstract] [Full Text] [Related]
8. Transfusion safety: Where are we today?
Luban NL
Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
[TBL] [Abstract][Full Text] [Related]
9. Safety of the blood supply: role of pathogen reduction.
Wu YY; Snyder EL
Blood Rev; 2003 Jun; 17(2):111-22. PubMed ID: 12642123
[TBL] [Abstract][Full Text] [Related]
10. Blood supply safety: an NHLBI perspective.
Glynn SA
Transfusion; 2008 Aug; 48(8):1541-4. PubMed ID: 18713102
[No Abstract] [Full Text] [Related]
11. [Post-transfusion parasite transmission: do the present controls fit with the EU directive?].
Garraud O; Elghouzzi MH
Transfus Clin Biol; 2005 Jul; 12(3):275-85. PubMed ID: 15949963
[TBL] [Abstract][Full Text] [Related]
12. Safe blood transfusion practices in blood banks of Karachi, Pakistan.
Kassi M; Afghan AK; Khanani MR; Khan IA; Ali SH
Transfus Med; 2011 Feb; 21(1):57-62. PubMed ID: 21029219
[TBL] [Abstract][Full Text] [Related]
13. Blood program in Japan: current status.
Ikeda H
Transfus Apher Sci; 2002 Apr; 26(2):129-33. PubMed ID: 12121069
[No Abstract] [Full Text] [Related]
14. Genomic screening for blood-borne viruses in transfusion settings.
Lee HH; Allain JP
Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
[No Abstract] [Full Text] [Related]
15. Is there a limit to the normality of blood products?
Hughes WG
Hematol J; 2001; 2(3):212. PubMed ID: 11920249
[No Abstract] [Full Text] [Related]
16. Approaches to minimize infection risk in blood banking and transfusion practice.
Lindholm PF; Annen K; Ramsey G
Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341
[TBL] [Abstract][Full Text] [Related]
17. Zoonoses and potential zoonoses transmitted by bats.
Hoar BR; Chomel BB; Argazz Rodriguez FJ; Colley PA
J Am Vet Med Assoc; 1998 Jun; 212(11):1714-20. PubMed ID: 9621877
[No Abstract] [Full Text] [Related]
18. Transfusion transmitted infectious agents, excluding hepatitis and human immunodeficiency viruses.
Leikola J
Acta Anaesthesiol Scand Suppl; 1988; 89():20-5. PubMed ID: 3067485
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-transmissible infections.
Vrielink H; Reesink HW
Curr Opin Hematol; 1998 Nov; 5(6):396-405. PubMed ID: 9814646
[TBL] [Abstract][Full Text] [Related]
20. HIV and the blood supply: an analysis of crisis decision making. Executive summary. The Institute of Medicine, National Academy of Sciences Committee to Study HIV Transmission Through Blood and Blood Products.
Leveton LB; Sox HC; Stoto MA
Transfusion; 1996 Oct; 36(10):919-27. PubMed ID: 8863781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
